This activity was planned with an overall goal to enable participants to evaluate and choose the best hypertension management strategy and understand the latest science on renal denervation.

Accreditation Statement 

In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page. 

 
Joint Accreditation 
 
In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement 

Physicians  

The ACCF designates this online enduring material for a maximum of up to 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses 
The ACCF designates this educational activity for a maximum of 1.5 continuing nursing education contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

 



MOC
Successful completion of this JACC Journal CME/MOC activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Target Audience: 

The primary target audience is general cardiologists as well as hypertension specialists, and advanced practice providers including nurse practitioners, physician assistants and pharmacists.
 

Important Dates: 
Date of Release: May 6, 2024
Term of Approval/Date of Expiration: April 6, 2025
 
Learner Objectives:  
Upon completion, learners should be able to:  

1. Identify disparities in hypertension management and the importance of overcoming these challenges. 
2. Evaluate and manage patients with resistant hypertension. 
3. Analyze which hypertensive patients are suitable for renal denervation treatment.
   
   
   

Acknowledgements:
Educational grant support provided by: Medtronic.

Faculty: 

Eugene Yang, MD, FACC
David Kandzari, MD, FACC
Wanpen Vongpatanasin, MD
Elliot Stein, MD, MS

Anna Krawisz, MD

Taisei Kobayashi, MD

By participating in this education, participants should be able to:  

​ 

1. ​Identify disparities in hypertension management and the importance of overcoming these challenges. 
2. ​Evaluate and manage patients with resistant hypertension. 
3. ​Analyze which hypertensive patients are suitable for renal denervation treatment.